D. E. Shaw & Co., Inc. - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$148,000
-78.3%
43,148
-54.9%
0.00%
-100.0%
Q1 2022$681,000
+180.2%
95,638
+228.3%
0.00%
Q4 2021$243,000
+115.0%
29,132
+80.0%
0.00%
Q3 2021$113,000
-91.0%
16,188
-69.2%
0.00%
-100.0%
Q2 2021$1,252,000
+16.7%
52,480
+0.7%
0.00%0.0%
Q1 2021$1,073,000
-88.9%
52,118
-86.8%
0.00%
-88.9%
Q4 2020$9,677,000
-31.4%
395,001
-20.7%
0.01%
-35.7%
Q3 2020$14,097,000
+263.3%
497,935
-38.9%
0.01%
+180.0%
Q2 2020$3,880,000
+122.2%
815,162
+66.6%
0.01%
+66.7%
Q1 2020$1,746,000
+40.0%
489,179
+35.4%
0.00%
+200.0%
Q4 2019$1,247,000
+20.6%
361,414
+40.1%
0.00%0.0%
Q3 2019$1,034,000
+1.7%
257,978
-18.3%
0.00%0.0%
Q2 2019$1,017,000
-48.1%
315,823
+10.7%
0.00%
-66.7%
Q1 2019$1,960,000
+40.8%
285,305
-7.3%
0.00%
+50.0%
Q4 2018$1,392,000
-36.9%
307,930
+5.9%
0.00%
-33.3%
Q3 2018$2,206,000
-11.2%
290,736
+0.6%
0.00%0.0%
Q2 2018$2,485,000
+12.7%
288,962
-3.8%
0.00%0.0%
Q1 2018$2,204,000
-42.9%
300,297
-21.1%
0.00%
-40.0%
Q4 2017$3,858,000
-56.2%
380,433
-30.7%
0.01%
-64.3%
Q3 2017$8,802,000
+47.7%
548,748
+4.1%
0.01%
+40.0%
Q2 2017$5,958,000
-8.6%
527,261
-8.8%
0.01%
-9.1%
Q1 2017$6,517,000
+22.3%
578,301
+7.4%
0.01%
+22.2%
Q4 2016$5,330,000
-17.4%
538,382
+2.5%
0.01%
-18.2%
Q3 2016$6,456,000
+2239.1%
525,302
+5429.5%
0.01%
+1000.0%
Q2 2016$276,0009,5000.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$55,018,5673.99%
Lion Point Capital, LP 691,803$1,646,4910.73%
Eversept Partners, LP 2,352,556$5,599,0830.47%
Soleus Capital Management, L.P. 1,820,983$4,333,9400.40%
Simplify Asset Management Inc. 550,626$1,310,4900.15%
Avoro Capital Advisors LLC 2,500,000$5,950,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 45,419$108,0970.07%
Knott David M Jr 70,000$1670.06%
XTX Topco Ltd 150,097$357,2310.06%
FEDERATED HERMES, INC. 8,981,717$21,376,4860.06%
View complete list of SERES THERAPEUTICS INC shareholders